dehydroepiandrosterone has been researched along with Chronic Fatigue and Immune Dysfunction Syndrome in 11 studies
Dehydroepiandrosterone: A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
dehydroepiandrosterone : An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.
| Excerpt | Relevance | Reference |
|---|---|---|
| "An association between chronic fatigue syndrome (CFS) and abnormalities of the hypothalamo-pituitary-adrenal axis has been described, and other adrenal steroid abnormalities have been suggested." | 2.71 | Levels of DHEA and DHEAS and responses to CRH stimulation and hydrocortisone treatment in chronic fatigue syndrome. ( Cleare, AJ; Miell, JP; O'Keane, V, 2004) |
| " ii) Evidence is presented to indicate that interstitial pneumonia was associated with increased risk for depression of which the emergence is a candidate subject causally related to the long-term use of glucocorticoid." | 2.71 | The clinical course of interstitial pneumonia alias chronic fatigue syndrome under the control of megadose vitamin C infusion system with dehydroepiandrosterone-cortisol annex. ( Kodama, M; Kodama, T, 2005) |
| "Chronic fatigue syndrome is defined by the Atlanta Centers for Disease Control (Atlanta, GA, USA) as debilitating fatigue lasting for longer than 6 months." | 1.31 | Serum concentrations of some metals and steroids in patients with chronic fatigue syndrome with reference to neurological and cognitive abnormalities. ( Carstens, ME; Emsley, RA; Hugo, F; Hurly, PR; Kiss, T; Mansvelt, E; Potocnik, FC; Taljaard, JJ; Theodorou, P; van Rensburg, SJ; van Zijl, P, 2001) |
| "The symptoms of Gulf War syndrome are compatible with the hypothesis that the immune system of affected individuals is biased towards a Th2-cytokine pattern." | 1.30 | Gulf War syndrome: is it due to a systemic shift in cytokine balance towards a Th2 profile? ( Rook, GA; Zumla, A, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (36.36) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jason, L | 1 |
| Sorenson, M | 1 |
| Sebally, K | 1 |
| Alkazemi, D | 1 |
| Lerch, A | 1 |
| Porter, N | 1 |
| Kubow, S | 1 |
| Papadopoulos, AS | 1 |
| Cleare, AJ | 2 |
| O'Keane, V | 1 |
| Miell, JP | 1 |
| Kodama, M | 1 |
| Kodama, T | 1 |
| Bentler, SE | 1 |
| Hartz, AJ | 1 |
| Kuhn, EM | 1 |
| Rook, GA | 1 |
| Zumla, A | 1 |
| Kuratsune, H | 1 |
| Yamaguti, K | 1 |
| Sawada, M | 1 |
| Kodate, S | 1 |
| Machii, T | 1 |
| Kanakura, Y | 1 |
| Kitani, T | 1 |
| De Becker, P | 1 |
| De Meirleir, K | 1 |
| Joos, E | 1 |
| Campine, I | 1 |
| Van Steenberge, E | 1 |
| Smitz, J | 1 |
| Velkeniers, B | 1 |
| Scott, LV | 2 |
| Salahuddin, F | 1 |
| Cooney, J | 1 |
| Svec, F | 2 |
| Dinan, TG | 1 |
| Dinan, T | 1 |
| van Rensburg, SJ | 1 |
| Potocnik, FC | 1 |
| Kiss, T | 1 |
| Hugo, F | 1 |
| van Zijl, P | 1 |
| Mansvelt, E | 1 |
| Carstens, ME | 1 |
| Theodorou, P | 1 |
| Hurly, PR | 1 |
| Emsley, RA | 1 |
| Taljaard, JJ | 1 |
1 review available for dehydroepiandrosterone and Chronic Fatigue and Immune Dysfunction Syndrome
| Article | Year |
|---|---|
Hypothalamic-pituitary-adrenal axis dysfunction in chronic fatigue syndrome.
Topics: Dehydroepiandrosterone; Fatigue Syndrome, Chronic; Humans; Hydrocortisone; Hypothalamic Diseases; Hy | 2011 |
2 trials available for dehydroepiandrosterone and Chronic Fatigue and Immune Dysfunction Syndrome
| Article | Year |
|---|---|
Levels of DHEA and DHEAS and responses to CRH stimulation and hydrocortisone treatment in chronic fatigue syndrome.
Topics: Adult; Area Under Curve; Body Mass Index; Corticotropin-Releasing Hormone; Cross-Over Studies; Dehyd | 2004 |
The clinical course of interstitial pneumonia alias chronic fatigue syndrome under the control of megadose vitamin C infusion system with dehydroepiandrosterone-cortisol annex.
Topics: Adult; Aged; Ascorbic Acid; Dehydroepiandrosterone; Depression; Fatigue Syndrome, Chronic; Female; F | 2005 |
8 other studies available for dehydroepiandrosterone and Chronic Fatigue and Immune Dysfunction Syndrome
| Article | Year |
|---|---|
Increased HDAC in association with decreased plasma cortisol in older adults with chronic fatigue syndrome.
Topics: Aged; Aged, 80 and over; Antioxidants; Dehydroepiandrosterone; Fatigue Syndrome, Chronic; Female; Ge | 2011 |
Prospective observational study of treatments for unexplained chronic fatigue.
Topics: Adolescent; Adult; Aged; Antioxidants; Coenzymes; Complementary Therapies; Dehydroepiandrosterone; F | 2005 |
Gulf War syndrome: is it due to a systemic shift in cytokine balance towards a Th2 profile?
Topics: Affect; Animals; Cytokines; Dehydroepiandrosterone; Depressive Disorder; Fatigue Syndrome, Chronic; | 1997 |
Dehydroepiandrosterone sulfate deficiency in chronic fatigue syndrome.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenocorticotropic Hormone; Adult; Dehydroepiandrostero | 1998 |
Dehydroepiandrosterone (DHEA) response to i.v. ACTH in patients with chronic fatigue syndrome.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Adult; Dehydroepiandrosterone; Fatigue Syndrome, Chroni | 1999 |
Differences in adrenal steroid profile in chronic fatigue syndrome, in depression and in health.
Topics: Adult; Dehydroepiandrosterone; Depressive Disorder, Major; Fatigue Syndrome, Chronic; Female; Health | 1999 |
A preliminary study of dehydroepiandrosterone response to low-dose ACTH in chronic fatigue syndrome and in healthy subjects.
Topics: Adrenocorticotropic Hormone; Adult; Analysis of Variance; Case-Control Studies; Dehydroepiandrostero | 2000 |
Serum concentrations of some metals and steroids in patients with chronic fatigue syndrome with reference to neurological and cognitive abnormalities.
Topics: Adult; Aluminum; Binding, Competitive; Cholesterol; Cognition Disorders; Copper; Dehydroepiandroster | 2001 |